Kaken Pharmaceutical (4521.TSE) Q2 2026 Earnings

13MayConfirmed
Q3 2025
Q4 2025
Q1 2026
Q2 2026
7.26
13.13
19
24.87

Details

Expected EPS
19.866031888722816
Actual EPS
19.582931292199998
Surprise EPS
-0.28
Surprise Percent
+1.43%

Description

Kaken Pharmaceutical (4521.TSE) has reported earnings of 19.582931292199998 per share for Q2 2026.

0 Comments

Share your thoughts